|By Marketwired .||
|July 11, 2014 01:36 PM EDT||
PORTLAND, OR -- (Marketwired) -- 07/11/14 -- Entia Biosciences, Inc. (OTCQB: ERGO) is excited to announce that its GROH brand will be an official sponsor of the 4th Annual, Battle of the Strands competition. The Battle of the Strands ("BOTS") is an International Beauty Competition, reaching 10,000+ professional stylists, trainers & salon owners. Teams compete to be chosen as the top salon with the final competition airing on Discovery Channel in December 2014. The BOTS platform provides GROH with an incredible opportunity to support the industry's brightest stars and educate thousands of professionals on GROH's next generation of skin care and hair care technology.
GROH utilizes the latest in Nutrigenomics technology to deliver powerful micronutrients working in synergy with the body's natural genetic transport systems. This revolutionary, new, patented technology provides a much higher degree of absorption and targeted nutrient delivery than other products can offer. All of the GROH products are designed to meet the growing consumer demand for natural and organic products which align with healthy lifestyle choices (free of toxic chemicals: sulfates, parabens, & formaldehyde), to reduce the signs of early aging and support the essential systems for skin, hair, and nail growth. "As an early adopter of the GROH® products I have experienced firsthand the many benefits GROH provides to me, my family, and my guests. It helps my hair, skin and nails look their best and keeps my body feeling healthy. The BOTS Competition is intense and we're excited to have GROH as our Exclusive Lifestyle and Wellness Sponsor," said Amy Michleb, National Director for Elizabeth Arden's Red Door Spa's Hair Department & Host of the 2014 Battle of the Strands competition.
About Battle of the Strands
The Battle of the Strands was the first extreme hair, makeup, nails, and wardrobe salon competition and has seen explosive growth over the past three years. The 2014 competition marks the fourth year anniversary of the live competition and the first year of broadcasted television. The competition is an intensive multi-month battle, across multiple states; teams are judged on hair, make-up, nails and fashion. The winning teams will come face-to-face for a final elimination challenge to pick the top salon in the US and competing countries. The final round of Battle of the Strands competition is in Las Vegas, on October 06, 2014.
"With our steady growth as a global platform for incredible artistry in beauty & fashion, having a partner like GROH, whose technology has been tested to achieve beauty from within, reinforces our dedication to total beauty. It's like a total makeover that has to start with our body," stated Mina Lu, Chairman of the Executive Committee, Battle of the Strands. "GROH highlights lifestyle & wellness as an integral part of beauty & fashion that every professional has been echoing to their clients."
GROH® is developed and manufactured by Total Nutraceutical Solutions, Inc., a subsidiary of Entia Biosciences, Inc. GROH® products contain the potent master antioxidant L-Ergothioneine, naturally amplified Vitamin D2, and other important micronutrients and co-factors found in plants and whole foods. These nutrients are unlocked, enhanced, and formulated into the Ergo Boost Complex, which works with the body's biological systems to fulfill the everyday nutritional needs that our modern lifestyles fail to provide. With regular use, the GROH® Ergo Boost product line has been shown to promote thicker, fuller hair and lashes, healthier skin, and increased nail strength and growth. For more information on the science behind this revolutionary new approach to health and beauty, please visit www.myGROH.com.
About Entia Biosciences, Inc.
Entia Biosciences, Inc. (OTCQB: ERGO) is an authority on the clinical effects of oxidative stress and free radical reactions and is bringing this expertise to the fields of food science biotechnology and Nutrigenomics. The Company identifies, scientifically validates, patents, and commercializes solutions that address multi-billion dollar markets for health, beauty and agriculture. For more information, please visit Entia's website at www.entiabio.com
Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Entia Biosciences with the Securities and Exchange Commission. Further information on risks faced by the Company and its shareholders are detailed in the Form 10-K for the year ended December 31, 2013 and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Entia does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
For more information please contact:
Chief Operating Officer
Entia Biosciences, Inc.
13565 SW Tualatin-Sherwood Rd Sherwood, OR, 97140
Email: [email protected]